Clinical Impact of PD-L1 Expression for Survival in Curatively Resected Colon Cancer

Citations

WEB OF SCIENCE

15
Citations

SCOPUS

16

초록

Background: Programmed death 1 (PD-1) and its ligand PD-L1 play a key dysfunction of T lymphocytes. The purpose of this study was to assess and compare the prognostic role of tumor- TILs and its relationship with PD-L1 expression in stage II and III colon cancer. Methods: Immunohistochemisty was used to assess the densities of CD8+, CD4+, and FOXP3+ cells, and PD-L1 expression in intraepithelial tumor site from 58 stage II and III colon cancers. These were evaluated for association with histopathologic features and overall survival. Results: PD-L1-positive tumors contained a higher number of CD8+ TILs with statistical significance (p = 0.001). CD4+ TILs showed positive correlation with PD-L1 expression (p = 0.034). There were no associations between PD-L1 expression and FOXP3+ TILs. Microsatellite instability (MSI)-high status (p = 0.001; Odd ration 18.0; 95% CI = 4.3–74.8) was the strongest prognostic factor along with mucinous/poor cell differentiation, CD8 and right tumor location was associated with PD-L1 expression (p = 0.024, 0.035 and 0.033, respectively). Conclusion: This study demonstrated that PD-L1 expression was associated with MSI-high, increased CD8+ TILs, mucinous and poor cell differentiation, and right-sided tumor location. © 2020 The Author(s). Published by Taylor & Francis Group, LLC.

키워드

biochemical markersCancer biomarkerschemotherapy
제목
Clinical Impact of PD-L1 Expression for Survival in Curatively Resected Colon Cancer
저자
Jung, D.H.Park, H.J.Jang, H.H.Kim, S.-H.Jung, Y.Lee, W.-S.
DOI
10.1080/07357907.2020.1793349
발행일
2020-08
유형
Article
저널명
Cancer Investigation
38
7
페이지
406 ~ 414

파일 다운로드